OPC: OPC Pharmaceutical Joint Stock Company - Summary | Jitta

OPC Pharmaceutical Joint Stock Company

VNM:OPC

Price
₫22,700.00
Loss Chance
49.2%
4.40JITTA SCORE
101.63%Over Jitta Line
Jitta Ranking
344 / 622
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (45)
Financial Strength (72)
Return to Shareholders (40)
Competitive Advantage (49)
Jitta Signs
Debt LevelLow Long Term Debt
CapExVery Low
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
4.40
101.63%
4.34
205.69%
3.94
171.55%
Pharmaceuticals
5.90
74.70%
4.60
133.75%
3.71
> 1,000%
COMPANY DESCRIPTION
OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, hormones, external use, digestion, pain relief, anti-inflammatory, health gifts, and other drugs. It also offers nutritional products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In addition, the company manufactures and trades pharmaceuticals, medical supplies, machinery, equipment, chemicals, cosmetics, food, and functional foods; production, trading, processing, import and export of traditional medicine, herbal medicine, medicines of natural origin; real estate business, freight transport, electricity; production and sale of alcoholic beverages, carbonated drinks; and cultivation, harvesting, processing, and trading of medicinal herbs and plants. OPC Pharmaceutical Joint Stock Company was founded in 1977 and is based in Ho Chi Minh City, Vietnam.